Literature DB >> 26350767

Impact of devascularization and tissue procurement on cell number and RNA integrity in prostatectomy tissue.

Rochelle Payne Ondracek1, Jinrong Cheng1,2, Kalyan J Gangavarapu3, Gissou Azabdaftari4, Jeff Woltz1, Elizabeth Brese4, Angela Omilian4, Wiam Bshara4, Wendy J Huss3,5, James L Mohler5,6, James R Marshall1.   

Abstract

BACKGROUND: Minimizing the time between tissue devascularization in robot-assisted laparoscopic radical prostatectomy (RALP) and tissue procurement should produce the highest quality tissue for research study. This study examines the relationship between intra-operative time and two indicators of tissue integrity: number of epithelial cells per gram of tissue and RNA integrity numbers (RINs). The study also compares the RIN values of tissue obtained intra-operatively by biopsy, before and after devascularization, to those from RALP specimen tissue, obtained through the routine research tissue procurement process.
METHODS: Prostate tissues from two series of patients were analyzed. In the first, tissue from 18 patients undergoing RALP was analyzed for number of epithelial cells per gram of tissue. In the second, RIN values of tissue from 46 patients involved in a clinical study were analyzed. RIN values were assessed from RALP specimen tissue as well as tissue removed intra-operatively by biopsy, before and after devascularization.
RESULTS: Time from RALP to tissue procurement was not significantly associated with number of epithelial cells per gram of tissue or with RIN values. RINs of biopsy tissue obtained intra-operatively before and after devascularization were similar. However, the RIN values of tissue from RALP specimens were significantly higher than those of biopsy tissue obtained either before or after devascularization.
CONCLUSIONS: Tissue quality, defined by number of epithelial cells or RIN values, was not affected by time between devascularization and procurement. Obtaining tissue from intra-operative biopsies, either before or after devascularization, is not necessary and actually produced lower RINs than found in tissue from RALP specimens, obtained through the routine research tissue procurement process.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26350767      PMCID: PMC4746721          DOI: 10.1002/pros.23087

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  9 in total

1.  Integrity of prostatic tissue for molecular analysis after robotic-assisted laparoscopic and open prostatectomy.

Authors:  Sara Best; Youssef Sawers; Vivian X Fu; Nima Almassi; Wei Huang; David F Jarrard
Journal:  Urology       Date:  2007-08       Impact factor: 2.649

2.  Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens.

Authors:  Atreya Dash; Ira P Maine; Sooryanarayana Varambally; Ronglai Shen; Arul M Chinnaiyan; Mark A Rubin
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis.

Authors:  Daniel W Lin; Ilsa M Coleman; Sarah Hawley; Chung Y Huang; Ruth Dumpit; David Gifford; Philip Kezele; Hau Hung; Beatrice S Knudsen; Alan R Kristal; Peter S Nelson
Journal:  J Clin Oncol       Date:  2006-07-05       Impact factor: 44.544

4.  Comparative biomarker expression and RNA integrity in biospecimens derived from radical retropubic and robot-assisted laparoscopic prostatectomies.

Authors:  Carmela Ricciardelli; Tina Bianco-Miotto; Shalini Jindal; Thomas J Dodd; Penelope A Cohen; Villis R Marshall; Peter D Sutherland; Hemamali Samaratunga; James G Kench; Ying Dong; Hong Wang; Judith A Clements; Gail P Risbridger; Robert L Sutherland; Wayne D Tilley; David J Horsfall
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07       Impact factor: 4.254

5.  Isolation and applications of prostate side population cells based on dye cycle violet efflux.

Authors:  Kalyan J Gangavarpu; Wendy J Huss
Journal:  Curr Protoc Toxicol       Date:  2011-02

6.  Central quadrant procurement of radical prostatectomy specimens.

Authors:  Carl Morrison; Richard Cheney; Candace S Johnson; Gary Smith; James L Mohler
Journal:  Prostate       Date:  2009-05-15       Impact factor: 4.104

7.  Biobanking after robotic-assisted radical prostatectomy: a quality assessment of providing prostate tissue for RNA studies.

Authors:  Harveer Dev; David Rickman; Prasanna Sooriakumaran; Abhishek Srivastava; Sonal Grover; Robert Leung; Robert Kim; Naoki Kitabayashi; Raquel Esqueva; Kyung Park; Jessica Padilla; Mark Rubin; Ashutosh Tewari
Journal:  J Transl Med       Date:  2011-07-26       Impact factor: 5.531

8.  Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity.

Authors:  Kalyan J Gangavarapu; Gissou Azabdaftari; Carl D Morrison; Austin Miller; Barbara A Foster; Wendy J Huss
Journal:  Stem Cell Res Ther       Date:  2013-10-25       Impact factor: 6.832

9.  Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme.

Authors:  Barbara A Foster; Kalyan J Gangavarapu; Grinu Mathew; Gissou Azabdaftari; Carl D Morrison; Austin Miller; Wendy J Huss
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

  9 in total
  2 in total

1.  Gene Expression in Single Cells Isolated from the CWR-R1 Prostate Cancer Cell Line and Human Prostate Tissue Based on the Side Population Phenotype.

Authors:  Kalyan J Gangavarapu; Austin Miller; Wendy J Huss
Journal:  Single Cell Biol       Date:  2016-09-12

Review 2.  Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee.

Authors:  Brian Gastman; Piyush K Agarwal; Adam Berger; Genevieve Boland; Stephen Broderick; Lisa H Butterfield; David Byrd; Peter E Fecci; Robert L Ferris; Yuman Fong; Stephanie L Goff; Matthew M Grabowski; Fumito Ito; Michael Lim; Michael T Lotze; Haider Mahdi; Mokenge Malafa; Carol D Morris; Pranav Murthy; Rogerio I Neves; Adekunle Odunsi; Sara I Pai; Sangeetha Prabhakaran; Steven A Rosenberg; Ragheed Saoud; Jyothi Sethuraman; Joseph Skitzki; Craig L Slingluff; Vernon K Sondak; John B Sunwoo; Simon Turcotte; Cecilia Cs Yeung; Howard L Kaufman
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 12.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.